New developments in ureteral stent design, materials and coatings

References

• Bloom DA, Clayman RV, McDougal E. Stents and related terms: a brief history.Urology54(4), 767–771 (1999).
   Google Scholar
• Finney RP. Experience with new double J ureteral catheter stent.J. Urol.120(6), 678–681 (1978).
   PubMed Web of Science ®Google Scholar
• Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterization of urinary symptoms in patients with ureteral stents.Urology59(4), 511–516 (2002).
   PubMed Web of Science ®Google Scholar
• El-Nahas AR, El-Assmy AM, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA. Self-retaining ureteral stents: analysis of factors responsible for patients’ discomfort.J. Endourol.20(1), 33–37 (2006).
   PubMed Web of Science ®Google Scholar
• Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility.J. Urol.169(3), 1065–1069 (2003).
   PubMed Web of Science ®Google Scholar
• Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure.J. Urol.169(3), 1060–1064 (2003).
   PubMed Web of Science ®Google Scholar
• Damiano R, Oliva A, Esposito C, De Sio M, Autorino R, D’Armiento M. Early and late complications of double pigtail ureteral stent.Urol. Int.69(2), 136–140 (2002).
   PubMed Web of Science ®Google Scholar
• Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG. The development and validation of a patient-information booklet on ureteric stents.BJU Int.88(4), 329–334 (2001).
   PubMed Web of Science ®Google Scholar
• Hosking DH, McColm SE, Smith WE. Is stenting following ureteroscopy for removal of distal ureteral calculi necessary?J. Urol.161(1), 48–50 (1999).
   Web of Science ®Google Scholar
• Denstedt JD, Wollin TA, Sofer M, Nott L, Weir M, D’A HR. A prospective randomized controlled trial comparing nonstented versus stented ureteroscopic lithotripsy.J. Urol.165(5), 1419–1422 (2001).
   Web of Science ®Google Scholar
• Byrne RR, Auge BK, Kourambas J, Munver R, Delvecchio F, Preminger GM. Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial.J. Endourol.16(1), 9–13 (2002).
   Web of Science ®Google Scholar
• Chen YT, Chen J, Wong WY, Yang SS, Hsieh CH, Wang CC. Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial.J. Urol.167(5), 1977–1980 (2002).
   Web of Science ®Google Scholar
• Hollenbeck BK, Schuster TG, Faerber GJ, Wolf JS Jr. Routine placement of ureteral stents is unnecessary after ureteroscopy for urinary calculi.Urology57(4), 639–643 (2001).
   Google Scholar
• Hollenbeck BK, Schuster TG, Seifman BD, Faerber GJ, Wolf JS Jr. Identifying patients who are suitable for stentless ureteroscopy following treatment of urolithiasis.J. Urol.170(1), 103–106 (2003).
   PubMedGoogle Scholar
• Mardis HK, Kroeger RM. Ureteral stents. Materials.Urol. Clin. North Am.15(3), 471–479 (1988).
   Google Scholar
• Tieszer C, Reid G, Denstedt J. Conditioning film deposition on ureteral stents after implantation.J. Urol.160(3 Pt 1), 876–881 (1998).
   PubMed Web of Science ®Google Scholar
• Riedl CR, Plas E, Hubner WA, Zimmerl H, Ulrich W, Pfluger H. Bacterial colonization of ureteral stents.Eur. Urol.36(1), 53–59 (1999).
   PubMed Web of Science ®Google Scholar
• Paick SH, Park HK, Oh SJ, Kim HH. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent.Urology62(2), 214–217 (2003).
   PubMed Web of Science ®Google Scholar
• Reid G, Habash M, Vachon D, Denstedt J, Riddell J, Beheshti M. Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation.Int. J. Antimicrob. Agents17(4), 317–319 (2001).
   PubMed Web of Science ®Google Scholar
• Wollin TA, Tieszer C, Riddell JV, Denstedt JD, Reid G. Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans.J. Endourol.12(2), 101–111 (1998).
   PubMed Web of Science ®Google Scholar
• Kehinde EO, Rotimi VO, Al-Hunayan A, Abdul-Halim H, Boland F, Al-Awadi KA. Bacteriology of urinary tract infection associated with indwelling J ureteral stents.J. Endourol.18(9), 891–896 (2004).
   PubMed Web of Science ®Google Scholar
• Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN. Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors.Urology58(4), 526–531 (2001).
   Web of Science ®Google Scholar
• el Faqih SR, Shamsuddin AB, Chakrabarti A et al. Polyurethane internal ureteral stents in treatment of stone patients: morbidity related to indwelling times.J. Urol.146(6), 1487–1491 (1991).
   Google Scholar
• Singh V, Srinivastava A, Kapoor R, Kumar A. Can the complicated forgotten indwelling ureteric stents be lethal?Int. Urol. Nephrol.37(3), 541–546 (2005).
   PubMed Web of Science ®Google Scholar
• Monga M, Klein E, Castaneda-Zuniga WR, Thomas R. The forgotten indwelling ureteral stent: a urological dilemma.J. Urol.153(6), 1817–1819 (1995).
   PubMed Web of Science ®Google Scholar
• Bultitude MF, Dasgupta P, Cynk M, Glass JM, Tiptaft RC. Lower ureteric obstruction: a complication of tailed ureteric stents.BJU Int.91(6), 581 (2003).
   Google Scholar
• Dunn MD, Portis AJ, Kahn SA et al. Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents.J. Endourol.14(2), 195–202 (2000).
   PubMed Web of Science ®Google Scholar
• Liatsikos EN, Hom D, Dinlenc CZ et al. Tail stent versus re-entry tube: a randomized comparison after percutaneous stone extraction.Urology59(1), 15–19 (2002).
   Google Scholar
• Yew J, Bellman G. Modified ‘tubeless’ percutaneous nephrolithotomy using a tail-stent.Urology62(2), 346–349 (2003).
   Google Scholar
• Gerber R, Nitz C, Studer UE, Danuser H. Spiral stent versus standard stent in patients with midsize renal stones treated with extracorporeal shock wave lithotripsy: which stent works better? A prospective randomized trial.J. Urol.172(3), 965–966 (2004).
   Google Scholar
• Stoller ML, Schwartz BF, Frigstad JR, Norris L, Park JB, Magliochetti MJ. An in vitro assessment of the flow characteristics of spiral-ridged and smooth-walled JJ ureteric stents.BJU Int.85(6), 628–631 (2000).
   Web of Science ®Google Scholar
• Olweny EO, Landman J, Andreoni C et al. Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model.J. Urol.167(5), 2198–2202 (2002).
   PubMed Web of Science ®Google Scholar
• Lingeman JE, Preminger GM, Berger Y et al. Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial.J. Urol.169(5), 1682–1688 (2003).
   PubMed Web of Science ®Google Scholar
• Auge BK, Ferraro RF, Madenjian AR, Preminger GM. Evaluation of a dissolvable ureteral drainage stent in a Swine model.J. Urol.168(2), 808–812 (2002).
   PubMed Web of Science ®Google Scholar
• Taylor WN, McDougall IT. Minimally invasive ureteral stent retrieval.J. Urol.168(5), 2020–2023 (2002).
   Google Scholar
• Ilker Y, Turkeri L, Dillioglugil O, Akdas A. Spontaneous fracture of indwelling ureteral stents in patients treated with extracorporeal shock wave lithotripsy: two case reports.Int. Urol. Nephrol.28(1), 15–19 (1996).
   Google Scholar
• Buchholz NN, Cannaby C, Fong R, Gray A, Andrews HO, Birch MJ. A new SWL titanium stent (Zebra Stent): resistance to shockwave exposure.J. Endourol.19(5), 584–588 (2005).
   PubMed Web of Science ®Google Scholar
• Moskovitz B, Vardi Y, Wislang M, Levin DR. Fracture of double-J ureteric stents: a report of two cases.Urol. Int.44(4), 241–243 (1989).
   Google Scholar
• Gorman SP, Tunney MM, Keane PF, Van Bladel K, Bley B. Characterization and assessment of a novel poly(ethylene oxide)/polyurethane composite hydrogel (Aquavene) as a ureteral stent biomaterial.J. Biomed. Mater. Res.39(4), 642–649 (1998).
   PubMed Web of Science ®Google Scholar
• Park JH, Cho YW, Kwon IC, Jeong SY, Bae YH. Assessment of PEO/PTMO multiblock copolymer/segmented polyurethane blends as coating materials for urinary catheters:in vitro bacterial adhesion and encrustation behavior.Biomaterials23(19), 3991–4000 (2002).
   PubMed Web of Science ®Google Scholar
• Watterson JD, Cadieux PA, Stickler D, Reid G, Denstedt JD. Swarming of Proteus mirabilis over ureteral stents: a comparative assessment.J. Endourol.17(7), 523–527 (2003).
   Google Scholar
• Tunney MM, Keane PF, Gorman SP. Assessment of urinary tract biomaterial encrustation using a modified Robbins device continuous flow model.J. Biomed. Mater. Res.38(2), 87–93 (1997).
   PubMed Web of Science ®Google Scholar
• Jones DS, Garvin CP, Gorman SP. Relationship between biomedical catheter surface properties and lubricity as determined using textural analysis and multiple regression analysis.Biomaterials25(7–8), 1421–1428 (2004).
   PubMedGoogle Scholar
• Marx M, Bettmann MA, Bridge S, Brodsky G, Boxt LM, Richie JP. The effects of various indwelling ureteral catheter materials on the normal canine ureter.J. Urol.139(1), 180–185 (1988).
   PubMed Web of Science ®Google Scholar
• Joshi HB, Chitale SV, Nagarajan M et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer.J. Urol.174(6), 2303–2306 (2005).
   PubMed Web of Science ®Google Scholar
• Isotalo T, Talja M, Valimaa T, Tormala P, Tammela TL. A bioabsorbable self-expandable, self-reinforced poly-l-lactic acid urethral stent for recurrent urethral strictures: long-term results.J. Endourol.16(10), 759–762 (2002).
   PubMed Web of Science ®Google Scholar
• Laaksovirta S, Isotalo T, Talja M, Valimaa T, Tormala P, Tammela TL. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-l-lactic and poly-l-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.J. Endourol.16(5), 311–315 (2002).
   Google Scholar
• Choong SK, Hallson P, Whitfield HN, Fry CH. The physicochemical basis of urinary catheter encrustation.BJU Int.83(7), 770–775 (1999).
   Web of Science ®Google Scholar
• Chitale SV, Scott-Barrett S, Ho ET, Burgess NA. The management of ureteric obstruction secondary to malignant pelvic disease.Clin. Radiol.57(12), 1118–1121 (2002).
   PubMed Web of Science ®Google Scholar
• Pauer W, Lugmayr H. Metallic wallstents: a new therapy for extrinsic ureteral obstruction.J. Urol.148(2 Pt 1), 281–284 (1992).
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Bellamy E. Nickel–titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction: 4-year experience.J. Urol.166(5), 1750–1754 (2001).
   PubMed Web of Science ®Google Scholar
• Daskalopoulos G, Hatzidakis A, Triantafyllou T et al. Intraureteral metallic endoprosthesis in the treatment of ureteral strictures.Eur. J. Radiol.39(3), 194–200 (2001).
   PubMed Web of Science ®Google Scholar
• Barbalias GA, Liatsikos EN, Kalogeropoulou C et al. Externally coated ureteral metallic stents: an unfavorable clinical experience.Eur. Urol.42(3), 276–280 (2002).
   PubMed Web of Science ®Google Scholar
• Amiel GE, Yoo JJ, Kim BS, Atala A. Tissue engineered stents created from chondrocytes.J. Urol.165(6 Pt 1), 2091–2095 (2001).
   PubMed Web of Science ®Google Scholar
• Smith TG III, Gettman M, Lindberg G, Napper C, Pearle MS, Cadeddu JA. Ureteral replacement using porcine small intestine submucosa in a porcine model.Urology60(5), 931–934 (2002).
   PubMed Web of Science ®Google Scholar
• Landman J, Olweny E, Sundaram CP et al. Laparoscopic mid sagittal hemicystectomy and bladder reconstruction with small intestinal submucosa and reimplantation of ureter into small intestinal submucosa: 1-year follow-up.J. Urol.171(6 Pt 1), 2450–2455 (2004).
   Google Scholar
• Desgrandchamps F, Moulinier F, Daudon M, Teillac P, Le Duc A. An in vitro comparison of urease-induced encrustation of JJ stents in human urine.Br. J. Urol.79(1), 24–27 (1997).
   PubMedGoogle Scholar
• Tunney MM, Gorman SP. Evaluation of a poly(vinyl pyrollidone)-coated biomaterial for urological use.Biomaterials23(23), 4601–4608 (2002).
   PubMed Web of Science ®Google Scholar
• Riedl CR, Witkowski M, Plas E, Pflueger H. Heparin coating reduces encrustation of ureteral stents: a preliminary report.Int. J. Antimicrob. Agents19(6), 507–510 (2002).
   PubMed Web of Science ®Google Scholar
• Tenke P, Riedl CR, Jones GL, Williams GJ, Stickler D, Nagy E. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy.Int. J. Antimicrob. Agents23(Suppl. 1), S67–S74 (2004).
   PubMed Web of Science ®Google Scholar
• Multanen M, Tammela TL, Laurila M et al. Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-l-lactic acid stents in rabbit urethra.Urol. Res.30(4), 227–232 (2002).
   PubMed Web of Science ®Google Scholar
• Stickler DJ. Biomaterials to prevent nosocomial infections: is silver the gold standard?Curr. Opin. Infect. Dis.13(4), 389–393 (2000).
   PubMed Web of Science ®Google Scholar
• Stickler DJ, Evans A, Morris N, Hughes G. Strategies for the control of catheter encrustation.Int. J. Antimicrob. Agents19(6), 499–506 (2002).
   PubMed Web of Science ®Google Scholar
• Airoldi F, Di MC, Ribichini F et al. 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease.Am. J. Cardiol.96(5), 664–667 (2005).
   PubMedGoogle Scholar
• Bakhai A, Booth J, Delahunty N et al. The SV stent study: a prospective, multicentre, angiographic evaluation of the BiodivYsio phosphorylcholine coated small vessel stent in small coronary vessels.Int. J. Cardiol.102(1), 95–102 (2005).
   PubMedGoogle Scholar
• Lowe R, Menown IB, Nogareda G, Penn IM. Coronary stents: in these days of climate change should all stents wear coats?Heart91(Suppl. 3), iii20–iii23 (2005).
   PubMed Web of Science ®Google Scholar
• Su SH. Novel coating to reduce medical device encrustation.Med. Device Technol.15(1), 12–14 (2004).
   Google Scholar
• Watterson JD, Cadieux PA, Beiko DT et al. Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation.J. Endourol.17(5), 269–274 (2003).
   PubMed Web of Science ®Google Scholar
• Granada JF, Kaluza GL, Raizner A. Drug-eluting stents for cardiovascular disorders.Curr. Atheroscler. Rep.5(4), 308–316 (2003).
   Google Scholar
• Beiko DT, Watterson JD, Knudsen BE et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy.J. Endourol.18(8), 723–730 (2004).
   PubMedGoogle Scholar
• Stewart MJ, Parikh S, Xiao G, Tonge PJ, Kisker C. Structural basis and mechanism of enoyl reductase inhibition by triclosan. J. Mol. Biol.290(4), 859–865 (1999).
   PubMed Web of Science ®Google Scholar
• Jones GL, Russell AD, Caliskan Z, Stickler DJ. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan.Eur. Urol.48(5), 838–845 (2005).
   PubMed Web of Science ®Google Scholar
• Cadieux PA, Chew BH, Knudsen BE et al. Triclosan loaded ureteral stents reduce Proteus mirabilis 296 infection in a rabbit UTI model.J. Urol. (2006) (In press).
   Google Scholar
• Chew BH, Cadieux PA, Reid G, Denstedt JD. In vitro activity of triclosan loaded ureteral stents against common bacterial uropathogens.J. Endourol.19(Suppl. 1), A10 (2005).
   Google Scholar
• McNair AM. Using hydrogel polymers for drug delivery.Med. Device Technol.7(10), 16–22 (1996).
   PubMedGoogle Scholar
• Livnat M, Beyar R, Seliktar D. Endoluminal hydrogel films made of alginate and polyethylene glycol: physical characteristics and drug-eluting properties.J. Biomed. Mater. Res. A75(3), 710–722 (2005).
   Google Scholar
• Slepian MJ. Polymeric endoluminal gel paving: therapeutic hydrogel barriers and sustained drug delivery depots for local arterial wall biomanipulation.Semin. Interv. Cardiol.1(1), 103–116 (1996).
   Google Scholar
• Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?Urology67(1), 35–39 (2006).
   PubMed Web of Science ®Google Scholar